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apoptotic signalingNeutrophils are themost abundant leukocyte and have a short lifespan, dying by apoptosis approximately ﬁve
days after leaving the bone marrow. Their apoptosis can be delayed at sites of inﬂammation to extend their
functional lifespan, but inappropriate inhibition of apoptosis contributes to chronic inﬂammatory disease.
Levels of the physiological iron chelator lactoferrin are raised at sites of inﬂammation and we have shown
previously that iron-unsaturated lactoferrin inhibited human neutrophil apoptosis, but the mechanisms
involved were not determined. Here we report that the anti-apoptotic effect of lactoferrin is dependent upon
its iron saturation status as iron-saturated lactoferrin did not affect neutrophil apoptosis. We also show that
the effect of lactoferrin is mediated at an early stage in apoptosis as it inhibited activation of
sphingomyelinase, generation of ceramide, activation of caspase 8 and Bax and cleavage of Bid. Lactoferrin
did not inhibit apoptosis induced by exogenous ceramide, supporting the proposal that it acts upstream of
ceramide generation. We therefore conclude that raised lactoferrin levels are likely to contribute to chronic
inﬂammation by delaying neutrophil apoptosis and that this is achieved by inhibiting proximal apoptotic
signaling events.gulation, Institute of Biomedical
, UK. Tel.: +44 121 414 4399;
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Neutrophils are the shortest lived cell in the body, surviving for
approximately 5 days in the circulation before dying spontaneously
by apoptosis [1,2]. Neutrophil apoptosis can be inhibited at sites of
infection in order to extend neutrophil bactericidal function [3], but
inappropriate extension of neutrophil survival can lead to chronic
inﬂammatory disease [4,5]. Improved understanding of the regulation
of neutrophil apoptosis in vivo may reveal novel therapeutic targets.
Reactive oxygen species (ROS) have been identiﬁed as primary
effectors of neutrophil spontaneous apoptosis [6–8] and we have
proposed a model for the induction of spontaneous neutrophil
apoptosis in which ROS mediate activation of sphingomyelinase,
generating ceramide at the cell membrane and inducing clustering
and activation of death receptors in lipid rafts leading to activation of
caspase 8 with subsequent cleavage of Bid and induction of the
mitochondrial death pathway [8]. If this model is correct then factors
that inﬂuence ROS generation at sites of inﬂammation would have the
potential to modulate neutrophil apoptosis in vivo and inﬂuence
disease pathogenesis.Here we have considered the role of physiological iron-binding
proteins in regulating neutrophil apoptosis and in particular their
mode of action. Trace amounts of "free" iron can catalyse the
production of hydroxyl radicals via the Fenton/Haber-Weiss reac-
tion [9] and thus inﬂuence neutrophil apoptosis. Lactoferrin is an
80-kDa iron-binding protein that is present in secondary granules in
neutrophils. The concentration of lactoferrin in the circulation is
normally low, i.e. 2.5 nM-7.5 nM, but at sites of inﬂammation this can
be as high as 2.5 μM [10]. Neutrophils release lactoferrin upon
activation and can bind lactoferrin, though a speciﬁc receptor has not
been characterised [11,12]. We have shown previously that iron-
unsaturated apo-lactoferrin was able to inhibit the spontaneous
apoptosis of human neutrophils in vitro [13], though the mechanism
of action was not determined.
2. Materials and Methods
2.1. Isolation and culture of human peripheral blood neutrophils
Neutrophils were isolated from the peripheral blood of healthy
human volunteers as previously described [14]. All donors gave
written informed consent prior to their participation. The purity of
isolated neutrophils was determined by Giemsa staining and light
microscopy and was routinely greater than 97%. Neutrophils were
cultured in RPMI1640 medium (Life Technologies, Paisley, UK)
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International Ltd, Haywards Heath, UK), 2 mM L-glutamine, 100 U/ml
penicillin and 100 μg/ml streptomycin (Sigma-Aldrich, Poole, UK), in
the presence or absence of a range of concentrations of human iron-
unsaturated apo-lactoferrin, iron-saturated holo-lactoferrin and iron-
unsaturated apo-transferrin and anhydrous ferric chloride, FeCl3 (all
from Sigma-Aldrich).
2.2. Measurement of neutrophil apoptosis
Neutrophil apoptosis was determined by two methods, observa-
tion of nuclear morphology and assessment of mitochondrial
membrane integrity. To determine apoptosis by morphology cytospin
preparations (3 min, 500 rpm; Cytospin 2; Shandon, Pittsburgh, PA)
weremadeanddifferentially stained (Diff-Quick;Gamidor,Didcot,U.K.)
and assessed for an apoptotic nuclear morphology [15]. Morphological
assessments were conﬁrmed by measurement of mitochondrial
permeability transition using uptake and retention of M5,5_,6,6_-
tetrachloro1,1_,3,3_-tetraethylbenzimidazolylcarbocyanineiodide, JC-1
(Sigma-Aldrich), measured by ﬂow cytometric analysis, as described
previously [8]. JC-1 ﬂuoresces in the red channel when present in the
mitochondria but ﬂuoresces in the green channel upon its release in to
the cytosol [16].
2.3. Measurement of Ceramide
Neutrophils were washed twice in sterile Tris Buffered Saline (TBS,
Sigma-Aldrich) and lipids extracted in chloroform:methanol according
to the Bligh and Dyer protocol. Ceramide species were measured by
HPLC as described previously [17] and the levels combined to give a
value for total ceramide.
2.4. Measurement of Caspase 8 activity
Activation of caspase 8 was measured by assessing cleavage of a
ﬂuorescently tagged caspase 8 substrate peptide and release of the
ﬂuorochrome AMC (R & D Systems, Abingdon, UK). The amount of
protein from each sample was measured using the BCA assay (Perbio
Science UK Ltd, Cramlington, UK). Results were expressed as relative
ﬂuorescence units (RFU) per 100 μg protein. Caspase 8 activity was
blocked by incubation of cells with 10 μM of the tetrapeptide caspase
inhibitor IETD-fmk to conﬁrm the speciﬁcity of the assay (Calbiochem,
Nottingham, UK).
2.5. Measurement of Bax activation
The 6A7 anti-Bax antibody is speciﬁc for the active conformation of
Bax and can be used tomeasure the degree of Bax activationwithin cells
[18]. Neutrophils were ﬁxed and permeabilised using PermeaFixTM
solution (Ortho Diagnostic Systems Inc, Raritan, NJ, USA) and stained
with 5 μg/ml afﬁnity puriﬁed mouse anti-human active Bax antibody
(6A7; Abcam, Cambridge, UK) or normal mouse IgG1 immunoglobulin
fraction (Dako UK Ltd, Ely, UK) as a negative control. Staining was
detected using a FITC conjugated goat anti-mouse IgG secondary
antibody (Southern biotechnology Inc, Birmingham, Al, USA).
2.6. Measurement of Bid cleavage and Mcl-1 expression by western
blotting
Full-length Bid (22 kDa) is cleaved by caspase 8 to generate the
15-kDa fragment (tBid) that promotes mitochondrial membrane
permeability transition and release of cytochrome c. Mcl-1 is an anti-
apoptotic protein that is lost during neutrophil apoptisis. Loss of full
length Bid and reduced Mcl-1 protein expression were detected by
Western blotting as previously described [8]. Brieﬂy, neutrophils
cultured for 0 to 20 hours in the absence or presence of 1.25 μM apo-lactoferrin were spun down and the pellet precipitated with ice-cold
10% trichloroacetic acid and the precipitated proteins spun down at
14000 g for 5 minutes at 4 °C. The precipitate was washed 3 times in
ice-cold acetone and taken up in SDS-PAGE sample buffer and
proteins were separated on 12% SDS-PAGE gels. Antibodies to Bid
(Biosource International) and Mcl-1 (Santa Cruz Biotechnology, CA,
USA) were used in Western blotting, and blots were developed by
enhanced chemiluminescence (ECL; Amersham Pharmacia, Amersham,
UK).
2.7. Measurement of sphingomyelinase expression and activity
Neutral sphingomyelinase (NSM) activity was measured using the
commercial Amplex® Red Sphingomyelinase assay kit (Invitrogen)
according to the manufacturer's instructions. Background ﬂuores-
cence was corrected by subtracting the values derived from a no
sphingomyelinase control and standardised to 100 μg of total protein.
Quantitative Real Time PCR (qPCR) was used to analyse neutral and
acid sphingomyelinase RNA expression in freshly isolated neutrophils.
Quantitative PCR was carried out based on the Assay on Demand
protocol (Applied Biosystems, Warrington, UK) using pre-mixed 20x
TaqMan probe and primer for either neutral or acid sphingomyelinase.
Detectionwasperformedusing theMx3005P®QPCRsystem(Stratagene,
La Jolla, CA,USA); cycling conditionswere set to50 °C for 2minutes, 95 °C
for 10 minutes, 45 cycles at 95 °C of 15 seconds and ﬁnally 1 minute at
60 °C. Datawas analysed usingMxPro™QPCR software (Stratagene) and
the relative quantities of mRNA determined against the β-actin gene.
2.8. Statistical analysis
Data presented here represent a minimum of three separate
experiments and where appropriate, data are expressed as mean±SD.
Statistical signiﬁcance was assessed by Student's t test and pb0.05 was
taken as a signiﬁcantly different value.
3. Results
3.1. Iron saturation abrogates the survival effect of lactoferrin
We have shown previously that iron-unsaturated apo-lactoferrin
could inhibit spontaneous neutrophil apoptosis in vitro in a concentra-
tion dependent manner [13]. To determinewhether the iron saturation
status of lactoferrinwould inﬂuence the ability of lactoferrin to enhance
neutrophil survival, we compared the effects of iron-unsaturated apo-
lactoferrin with iron-saturated holo-lactoferrin on spontaneous neu-
trophil apoptosis. As shown in Fig. 1A, iron-unsaturated apo-lactoferrin
inhibited neutrophil apoptosis, measured by either JC-1 retention by
mitochondria or changes to nuclear morphology, but iron-saturated
holo-lactoferrinwas not able to inhibit neutrophil apoptosis. In addition
inclusion of FeCl3 in the medium abrogated the survival effects of apo-
lactoferrin (data not shown). To investigate the possibility that the
effects of lactoferrin might also have an extracellular component, we
determined whether the iron chelator transferrin could also delay
neutrophil apoptosis. Neutrophils do not express the transferrin
receptor [18]. As shown in Fig. 1c iron-unsaturated apo-transferrin
had no effect on the survival of neutrophils even after culture was
extended to 20 h.
3.2. Apo-lactoferrin inhibits activation of sphingomyelinase in
neutrophils
We have proposed that neutrophil apoptosis is initiated by loss of
redox status and accumulation of ROS leading to activation of
sphingomyelinase, resulting in the generation of ceramide and
activation of death receptor signaling [8]. However in our previous

















Fig. 1. Iron-unsaturated lactoferrin but not iron-saturated lactoferrin inhibits
spontaneous neutrophil apoptosis. A. Human neutrophils were incubated with
medium alone or with medium containing 1.25 μM iron-unsaturated apo-lactoferrin
(Apo-LTF) or 1.25 μM iron saturated holo-lactoferrin (Holo-LTF). Apoptosis was
measured by analysis of nuclear morphology (ﬁlled bars) or JC-1 retention by
mitochondria (open bars) after 9 h in culture and data are presented as the % of
apoptotic cells. B. Neutrophils were incubated with medium alone or with medium
containing 0.125 – 1.25 μM iron-unsaturated apo-transferrin (Apo-TF) and apoptosis
measured by analysis of nuclear morphology after 20 h in culture. Data are mean±SD
(n=3) and * indicates pb0.05, for treated versus control.
Fig. 2. Apo-lactoferrin inhibits neutral sphingomyelinase activity in neutrophils.
A. Expression of ASM and NSM in freshly isolated neutrophils was determined by
quantitative PCR. Data are mean±SD (n=3). B. NSM enzymatic activity was measured
in freshly isolated neutrophils (0 h) and neutrophils cultured in the absence (6 h)
or presence (apo-LTF) of 1.25 μM iron-unsaturated apo-lactoferrin for 6 h. The
data are expressed as NSM activity per mg protein per minute and are mean±SD
(n=7).* indicates pb0.05.
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been shown to be sensitive to redox status [19]. We therefore
measured expression of both acid (ASM) and neutral sphingomyelinase
(NSM) by quantitative PCR. Fig. 2A shows that neutrophils expressed
both forms of sphingomyelinase, though NSM was the dominant form.
However, when we attempted to determine sphingomyelinase activity
enzymatically as neutrophils aged in culture, we found a signiﬁcant
increase in NSM with time (Fig. 2B), but we could not reproducibly
detect ASM activity. These data suggest that NSM is the major source of
ceramide during neutrophil apoptosis. Importantly we showed that
iron-unsaturated apo-lactoferrin was able to inhibit NSM activation as
neutrophils aged in culture (Fig. 2B).
3.3. Apo-lactoferrin inhibits early signalling events in neutrophil
apoptosis
To determine if the inhibition of sphingomyelinase activation by
apo-lactoferrin was sufﬁcient to impact upon downstream apoptotic
signalling we assessed the effect of apo-lactoferrin upon ceramide
generation, caspase 8 activation, Bax activation and Bid cleavage and
loss of the major neutrophil anti-apoptotic protein Mcl-1. As shown in
Fig. 3A, freshly isolated neutrophils contained minimal amounts of
ceramide which increased signiﬁcantly by 6 hours of culture (pb0.05).
Increased ceramide levels were not seen in neutrophils treated with
apo-lactoferrin (Fig. 3A). In addition, the increase in caspase 8 activity
seen during spontaneous neutrophil apoptosis was inhibited by apo-
lactoferrin, but not by holo-lactoferrin (Fig. 3B).
Bax activation and insertion into the outermitochondrialmembrane
contributes to mitochondrial permeability transition and initiation ofthe mitochondrial cell death pathway [20]. The conformational change
associated with activation can be detected using the 6A7 antibody.
Fig. 3C shows that lactoferrin inhibited the Bax activation that occurred
during spontaneous neutrophil apoptosis. Bid is cleaved to tBid by
caspase 8 and subsequently also inserts in to the mitochondrial
membrane [21]. Iron-unsaturated lactoferrin also inhibited the loss of
full length Bid during spontaneous neutrophil apoptosis (Fig. 3D). Loss
ofMcl-1 is amajor driver for spontaneous neutrophil apoptosis [22] and
Fig. 3D shows that apo-lactoferrin was able to prevent the down-
regulation of this protein as neutrophils aged in culture. Taken together
these data suggest that lactoferrin interferes with neutrophil apoptosis
at an early stage in the apoptotic process.
3.4. Apo-lactoferrin cannot inhibit apoptosis induced by exogenous
ceramide
If lactoferrin is acting upstream of ceramide generation it should
not be able to block apoptosis induced by addition of exogenous
ceramide. Fig. 4 shows that addition of exogenous ceramide to
neutrophils was able to increase neutrophil apoptosis signiﬁcantly
(pb0.02) and that this could not be blocked by lactoferrin. These data
support the proposal that lactoferrin acts upstream of ceramide
generation at the level of sphingomyelinase activation.
4. Discussion
Here we conﬁrm that the physiological iron binding protein
lactoferrin was able to inhibit neutrophil spontaneous apoptosis and
show that the anti-apoptotic effect was entirely dependent upon its
iron saturation status. Previous work has shown that in zymosan
stimulated neutrophils iron bound to lactoferrin is 5000 times more
potent than FeCl3 in generating hydroxyl radicals. Furthermore iron-
unsaturated lactoferrin was able to reduce hydroxyl radical genera-


















































































Fig. 3. Apo-lactoferrin inhibits early signalling events in neutrophil apoptosis. Neutrophils were incubated with medium alone (0 h and 6 h) or with medium containing 1.25 μM
iron-unsaturated apo-lactoferrin (apo-LTF), 1.25 μM iron-saturated holo-lactoferrin (Holo-LTF) for 6 hours. A. Lipid extracts were prepared and analysed for ceramide content by
HPLC. Data are mean±SD (n=3) and are expressed relative to those in freshly isolated cells. * indicates pb0.02. B. Caspase 8 activity was measured using a ﬂuorometric assay and
data are expressed as RFU per μg protein relative to the value for freshly isolated cells (0 h). Data are mean±SD (n=4) and *indicates pb0.05 compared to the 6 h value. C. Bax
activation was measured by immunostaining and ﬂow cytometry using an antibody speciﬁc for the active conformation of Bax. Data are expressed as % cells positive for the active
conﬁrmation of Bax and are mean±SD (n=5), * indicates pb0.04. D. Neutrophil proteins were extracted after incubation of cells with medium alone (0 h) and after 9 h in the
absence (9 h) or presence (+apoLTF) of 1.25 μM apo-lactoferrin (apo-LTF) or 1.25 μM holo-lactoferrin (holo-LTF). Bid activation, assessed by the loss of full length 22 kDa Bid, and
loss of Mcl-1 were both detected by western blotting. The image shown is representative of three separate experiments.
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ablated by reduction of its iron chelating ability by addition of FeCl2
[27], adding support to our suggestion that the ability to prevent
hydroxyl radical generation via the Fenton reaction is fundamental to
the effects of iron chelators on neutrophil apoptosis. Others have
reported that generation of hydroxyl radicals is involved in both
spontaneous and activation-induced neutrophil apoptosis [7]. Taken
together these data suggest that the ability of iron-unsaturated
lactoferrin to inhibit neutrophil spontaneous apoptosis is dependent
upon its iron saturation status and its effects may be mediated by its
ability to reduce hydroxyl radical generation.Fig. 4. Apo-lactoferrin does not inhibit apoptosis induced by exogenous ceramide.
Neutrophils were incubated for 9 h in medium alone, medium containing 100 ng/ml C8
ceramide or 100 ng/ml C8 ceramide and 1.25 μM iron-unsaturated apo-lactoferrin
(apoLTF) and apoptosis determined by DiOC6 staining. Data are mean±SD (n=3) and
* indicates pb0.02.We have suggested previously that ROS are involved in the
initiation of neutrophil spontaneous apoptosis via their ability to
activate death receptor signalling in the absence of death receptor
ligation [8]. A similar mechanism has been demonstrated for
apoptosis induced by chemotherapeutic agents and UV-irradiation
[24]. This mode of apoptosis initiation involves the activation of
sphingomyelinase, leading to the generation of ceramide-rich lipid
rafts, which then induce activation of death receptors such as Fas. In
our previous work we showed that neutrophil apoptosis was reduced,
but not completely blocked in ASM −/− mice [8], but we did not
determine whether ASM was activated during human neutrophil
apoptosis. Here we showed that NSM was the dominant sphingo-
myelinase at the mRNA level, that NSM enzymatic activity increased
dramatically as human neutrophils aged and this was inhibited by
apo-lactoferrin. In contrast we could not detect ASM activity during
spontaneous human neutrophil apoptosis and we therefore propose
that although ASM does play a role in early events in neutrophil
apoptosis in mice [8], NSM is likely to be the major source of ceramide
generated as human neutrophils enter apoptosis spontaneously.
Interestingly, a recent report has revealed that both ASM and NSM
are redox sensitive, but that they are activated by distinct reactive
oxygen species. NSM is activated predominantly by hydroxyl radicals,
whereas ASM is activated preferentially by peroxynitrite [25].
Moreover, previous work has shown that generation of hydroxyl
radicals is involved in neutrophil apoptosis [7] and apo-lactoferrin has
been shown to reduce generation of hydroxyl radicals by neutrophils
[26]. Taken together these data add support to our proposal that
1826 N. Francis et al. / Biochimica et Biophysica Acta 1813 (2011) 1822–1826hydroxyl radical generation and NSM activation is the target of apo-
lactoferrin in regulating neutrophil apoptosis.
Our data also showed that lactoferrin was able to block several
downstream events in death receptor signaling in neutrophil apoptosis,
such as caspase8 activation, Bid cleavage and lossofMcl-1. Crucially, the
ﬁnding that neutrophil apoptosis could still be induced in the presence
of lactoferrin if exogenous ceramide was supplied, supports our
suggestion lactoferrin's actions include the blocking of the initial
activation of sphingomyelinase. Recently, others have shown that
cathepsin D is involved in activation of caspase 8 during neutrophil
apoptosis and that the release of cathepsin D from azurophilic granules
into the cytosol was ROS dependent [23]. Future studies in our group
will investigatewhether lactoferrin also inhibits this release of cathepsin
D into the cytoplasm. We have also to consider that lactoferrin may
provide survival signals via othermeans and in this context others have
shown that iron-unsaturated lactoferrin also increased adherence of
neutrophils to endothelial cells [28]. Although not investigated in our
study it is possible that such an effect would provide an additional
contact-mediated survival signal.
4.1. Conclusions
Iron-unsaturated apo-lactoferrin inhibits spontaneous apoptosis
in human neutrophils, a process which is dependent upon the iron
saturation status of this agent and involves blockade of the very
earliest events in the apoptosis process in these short lived cells.
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